India Single-use Bioprocessing Probes And Sensors Market Size | Companies
The India single-use bioprocessing probes and sensors market size was exhibited at USD 83.95 million in 2023 and is projected to hit around USD 275.78 million by 2033, growing at a CAGR of 12.63% during the forecast period 2024 to 2033.
| Report Coverage | Details |
| Market Size in 2024 | USD 94.55 Million |
| Market Size by 2033 | USD 275.78 Million |
| Growth Rate From 2024 to 2033 | CAGR of 12.63% |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Segments Covered | Type, Workflow, End-use |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Key Companies Profiled | Thermo Fisher Scientific; Sartorius AG; PreSens; Precision Sensing GmbH; Hamilton Company; Mettler-Toledo India Private Limited; PARKER HANNIFIN CORP; Danaher; Saint-Gobain |
The growth of the market can be attributed to the rising demand for biopharmaceuticals and the increasing popularity of disposable systems in preclinical trials. Furthermore, the commercial benefits of the products, such as cost-effectiveness and reduced contamination risk, are driving the demand for single-use bioprocessing probes and sensors. The growing demand for personalized medicines and the need for faster and more efficient drug development processes are further fueling the adoption of single-use bioprocessing technologies in India.
The implementation of single-use technology (SUT) in biomanufacturing processes offers several advantages that resonate throughout the Indian biopharmaceutical industry. Single-use systems significantly reduce the risk of cross-contamination, ensuring product purity and integrity, which is crucial for the growing domestic biosimilars and biologics market. By eliminating the need for cleaning and sterilization between batches, these systems enhance operational efficiency, leading to shorter turnaround times and increased productivity - a key benefit for Indian manufacturers aiming to scale up and meet the rising domestic and global demand for biopharmaceuticals.
The commercial advantages of single-use sensors are particularly relevant for the Indian market, where companies are increasingly focused on optimizing their processes and staying competitive. These benefits, including streamlined operations, reduced costs, enhanced flexibility, and improved regulatory compliance and product quality, make single-use sensors an attractive option for Indian biomanufacturers. The adoption of disposable bioreactors and associated single-use sensors and probes can help Indian companies lower their capital expenditure and achieve faster turnaround times, which are critical in the fast-paced domestic market.
The rising demand for improved bioprocess monitoring devices is another major factor expected to drive the market growth for single-use bioprocessing probes and sensors in India. Regulatory bodies like the Central Drugs Standard Control Organization (CDSCO) require stringent quality control and assurance in bioprocessing, and enhanced monitoring ensures compliance with Good Manufacturing Practices (GMP) and other regulatory standards. Initiatives such as the Indian government's focus on promoting the domestic manufacturing of pharmaceutical and biotechnology products are further encouraging the adoption of advanced monitoring tools like single-use sensors to ensure product quality and process efficiency in the country.
Based on type, pH sensors held the largest revenue share of 20.24% in 2023 and are expected to grow at the fastest CAGR over the forecast period. The single-use pH sensor segment is driven by the widespread adoption and increasing penetration of these sensors in the country. The high usage rate of pH sensors, essential for measuring the acidity and alkalinity of water and solutions, has been a key factor behind the segment's success. Moreover, the development of advanced pH sensors with integrated temperature monitoring capabilities fuels the demand among Indian biopharmaceutical manufacturers. These technological advancements enable companies to enhance their process control and optimization, making them more attractive to leading pharmaceutical firms in the country.
The oxygen sensors segment is expected to register a significant CAGR over the forecast period. The growth rate is driven by the growing demand of the biopharmaceutical industry for efficient and accurate oxygen monitoring during the production of biologics, such as monoclonal antibodies and vaccines. Single-use oxygen sensors offer significant advantages, such as reduced contamination risks, lower costs by eliminating the need for cleaning and sterilization, and seamless integration into disposable bioprocessing systems. These benefits have been crucial in driving the adoption of single-use oxygen sensors among Indian biopharmaceutical manufacturers as they seek to enhance their production efficiency and meet the growing demand for biologics in the domestic and global markets.
Based on workflow, the market is segmented into upstream and downstream segments. The upstream segment dominated the market with a market share of 73.49% in 2023 and is anticipated to grow at the fastest CAGR over the forecast period. The upstream segment is driven by the increasing adoption of these technologies among leading pharmaceutical firms such as Thermo Fisher Scientific, Inc. The effective control and monitoring of critical process parameters, such as dissolved oxygen, temperature, and pH, through specialized single-use sensors, is crucial in driving the adoption of these technologies in the upstream segment, as companies enhance their manufacturing efficiency and focus on the rising demand for biologics and biosimilars in the country.
The downstream segment is expected to grow at a significant CAGR over the forecast period. The downstream segment is experiencing growth, fueled by the demand for flexible and scalable bioprocessing capabilities. Downstream processing is critical for separating, isolating, and purifying products from cell cultures and necessitates adjustable production volumes to align with market needs. The popularity of single-use bioprocessing probes and sensors in this domain is on the rise due to their versatility and the variety of sizes available, simplifying production scalability. This versatility is crucial in encouraging Indian biopharmaceutical firms to integrate these technologies into their operations, aiming to streamline their downstream processes and satisfy the increasing domestic and international demand for biologics and biosimilars.
Based on end use, the market is segmented into biopharmaceutical & pharmaceutical companies, CROs & CMOs, academic & research institutes and other end use. The biopharmaceutical & pharmaceutical companies dominated the segment with a market share of 42.0% in 2023. Indian giants such as Sartorius AG invest in advanced single-use systems to enhance their manufacturing capabilities and meet the rising global demand for biopharmaceuticals. The consistent introduction of new and innovative single-use bioprocessing products by domestic and international players fuels the adoption of these technologies in the Indian market. For instance, Biocon, a major Indian biopharmaceutical company, has implemented single-use bioprocessing solutions across its manufacturing facilities to improve efficiency and reduce cost.
The CROs & CMOs segment is expected to grow at the fastest CAGR over the forecast period. Indian CROs such as Syngene International invested in these technologies to enhance capabilities, improve efficiency, and maintain compliance, making it an attractive partner for outsourcing. The government's initiatives to promote India as a global biopharma hub have further accelerated the adoption of single-use bioprocessing solutions among CMOs and CROs in the country.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the India single-use bioprocessing probes and sensors market
Type
Workflow
End-use
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers